Have a personal or library account? Click to login
Hypereosinophilic syndrome presenting as eosinophilic gastroenteritis exacerbated by clopidogrel bisulphate Cover

Hypereosinophilic syndrome presenting as eosinophilic gastroenteritis exacerbated by clopidogrel bisulphate

Open Access
|Sep 2023

Abstract

Clopidogrel is a widely prescribed prodrug with antithrombotic activity that functions by irreversibly inhibiting the P2Y12 receptors on platelets; nevertheless, drug-induced eosinophilia from this drug is rarely reported. An 81-year-old man was diagnosed with cerebral infarction 2 months earlier and was admitted to our hospital with rash, fever, wheezing, and stomach discomfort after being initiated with clopidogrel treatment. Based on his medical history, chest CT, and gastroscopy, we diagnosed him with clopidogrel-induced hypereosinophilic syndrome. After discontinuation of clopidogrel, the eosinophilia and symptoms improved. In cases of drug-induced eosinophilia, it is important to obtain a detailed medical history.

DOI: https://doi.org/10.2478/rjim-2023-0022 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 216 - 221
Submitted on: May 12, 2023
|
Published on: Sep 5, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Taro Horino, Hiroshi Ohnishi, Masahiro Komori, Yoshio Terada, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.